[Recombinant human alfa2-interferon (reaferon) in ointment form in the treatment of various diseases of the skin and mucosa]

V V Parfenov; V N Grebeniuk; E I Abramova; Iu V Voronin; V V Bumialis; T N Volodina; L A Denisov

[Recombinant human alfa2-interferon (reaferon) in ointment form in the treatment of various diseases of the skin and mucosa]

Antibiot Khimioter. 1990 Sep;35(9):38-40.

[Article in Russian]

Authors

V V Parfenov¹, V N Grebeniuk, E I Abramova, Iu V Voronin, V V Bumialis, T N Volodina, L A Denisov

Affiliation

¹ Institute of Immunology, Ministry of Medical Industry of the USSR, Moscow Region.

PMID: 2275591

Abstract

Clinical trials of the gene engineered human alpha 2-interferon as ointment were performed. The ointment was used in the treatment of patients with relapsing herpes of various localization, relapsing aphthous stomatitis and pemphigus vulgaris. It was shown that the ointment was harmless and its therapeutic effect was favourable. The preparation is recommended for introduction into the practice of public health.

Publication types

Case Reports
Clinical Trial

MeSH terms

Adult
Female
Herpes Simplex / drug therapy
Humans
Interferon Type I / adverse effects
Interferon Type I / therapeutic use*
Interferon alpha-2
Interferon-alpha
Male
Middle Aged
Mucous Membrane / drug effects
Ointments
Pemphigus / drug therapy
Recombinant Proteins
Skin Diseases / drug therapy*
Stomatitis, Aphthous / drug therapy

Substances

Interferon Type I
Interferon alpha-2
Interferon-alpha
Ointments
Recombinant Proteins